BefejeződöttFázis nélkül
The Effect of NP-2006 on Sleep Quality and Health
A legfontosabb adatok
- Ki végzi
- Hanpoong Nature Pharm Co., Ltd.
- Hol
- Dél-Korea1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 48 fő vett részt
- Kezdés
- 2023. máj. 12.
- Befejezés
- 2025. aug. 13.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- NP-2006
- Placebo
- A regiszteradat frissítve
- 2026. március 27.
Ki vehet részt
- Életkor
- 19 év – 65 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 20 feltétel megnézéseKevesebb
Ki vehet részt
- Those who agreed to participate in this study and signed a written consent form
- Adults aged 19 to 65 years, male or female
- Those with poor sleep quality (PSQI score > 5 points)
Ki nem vehet részt
- Those taking medications (corticosteroids, psychotropic medications, etc.) that could affect sleep within 1 month of the first visit or expected to take them during the study participation
- Those receiving hormone therapy
- Those with the following conditions:; Snoring, sleep apnea, restless legs syndrome, periodic limb movement disorder (PLMD), depression, narcolepsy, or respiratory disease that cause sleep disturbances; Itching, nocturia, chronic pain, or muscle cramps that affect sleep; Uncontrolled diabetes or hypertension
- Those who are hypersensitive to ingredients in the test or control foods or have experienced severe food allergies
- Those with severe sleep disturbances (ISI ≥ 22 points)
- Those with severe daytime sleepiness (ESS ≥ 16 points)
- Those experiencing changes that could cause excessive stress within 2 weeks of the first visit: death of a spouse, family discord, lawsuits/disputes, sudden financial difficulties, immigration, etc
- Those who regularly consume excessive alcohol; Men > 210 g/week (approximately 4 bottles of soju/week, approximately 4 glasses/day); Women > 140 g/week (approximately 2.5 bottles of soju/week, approximately 2.5 glasses/day)
- Those who smoke excessively (> 10 cigarettes/day) or show withdrawal symptoms
- Those who consume excessive amounts of caffeine (> 3 cups/day)
- Those who work night shifts or have irregular bedtimes due to their job
- Those who have traveled or plan to travel long distances to a country with a different time zone within 1 month of the first visit
- Those with a BMI of 18 kg/m2 or less or 35 kg/m2 or more
- Those who have continuously taken herbal medicines or health functional foods that may affect sleep within 1 month of the first visit
- Those who have participated in a clinical trial within 1 month of the first visit
- Those who are pregnant or lactating, or who are planning to become pregnant
- Those who the researcher deems unsuitable for participation in this study
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The main objective will be to assess the effect of NP-2006 on sleep efficiency in volunteers presented with persistent subclinical insomnia
A vizsgálat 2 csoportja
- Sequence A (NP-2006 first, then Placebo)A vizsgált kezelés
Group that took tablets containing 500mg of NP-2006 (NP-2006, crystalline cellulose, tapioca starch, hydroxypropylmethylcellulose, etc.) 30 to 60 minutes before going to sleep
Kezelés: NP-2006 és Placebo
- Sequence B (Placebo first, then NP-2006)Placebo, összehasonlításként
Group that took tablets not containing NP-2006 (crystalline cellulose, maltodextrin, lactose mixed powder, hydroxypropylmethylcellulose, etc.) 30 to 60 minutes before bedtime
Kezelés: NP-2006 és Placebo
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Effect of NP-2006 on Sleep Efficiency and Quality in Healthy Volunteers With Persistent Subclinical Insomnia
- A regiszteradat frissítve
- 2026. március 27.